Search results
Cancer biologist Scott Lowe uses genetically engineered mouse models to study how the genetic alterations in cancer cells contribute to tumorigenesis, alter treatment response, and create molecular vulnerabilities that may be targeted therapeutically.
Scott William Lowe (born October 4, 1963) is Chair of the Cancer Biology and Genetics Program in the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center. He is recognized for his research on the tumor suppressor gene, p53, which is mutated in nearly half of cancers.
Biologist Scott W. Lowe , Chair of the Cancer Biology and Genetics Program and the Geoffrey Beene Cancer Research Center, is an expert on the processes that naturally inhibit cancer development.
Oct 21, 2019 · Scott W. Lowe, PhD, Chair of the Cancer Biology and Genetics Program at the Sloan Kettering Institute (SKI), Howard Hughes Medical Institute Investigator, and Chair of the Geoffrey Beene Cancer Research Center, has been elected to the National Academy of Medicine (NAM), one of the highest honors bestowed upon scientists worldwide.
Scott W. Lowe, PhD. Investigator • 2005-Present. Dr. Lowe is a member and chair of the Cancer Biology and Genetics Program at Memorial Sloan Kettering Cancer Center, the chair of Geoffrey Beene Cancer Research Center, and a professor at Weill Cornell Graduate School of Medical Sciences.
Scott W. Lowe is Chair of the Cancer Biology and Genetics Program at Memorial Sloan Kettering Cancer Center (MSKCC) in New York City and an Investigator for the Howard Hughes Medical Institute.
May 16, 2024 · Dr. Scott Lowe is a Member and Chair of the Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center and an Investigator at Howard Hughes Medical Institute.
